New guidelines for the treatment of patients with high cholesterol may, or may not, be appropriate for persons with type 2 diabetes. Here are the pros and cons.
Activation of opioid receptors with novel approaches may prevent hypoglycemia and lead to safer intensive glycemic control, according to a study reported at the American Diabetes Association 74th Scientific Sessions.